SCHEMBL1147882

SCHEMBL1147882

C=CCCC1=CCONC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575549 0.72
SCHEMBL224625 0.68
SCHEMBL15923996 0.63
SCHEMBL216058 0.61
SCHEMBL11528390 0.59 USP2 (0.30)
SCHEMBL225112 0.58
SCHEMBL3402274 0.57
SCHEMBL10628997 0.56
SCHEMBL15528024 0.53
SCHEMBL8646549 0.52 USP2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124518-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS INC (US) 2024-04-18 US disclosed
US-20220017569-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS, INC. 2022-01-20 US disclosed
EP-3492492-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS Aileron Therapeutics, Inc. (US) 2019-06-05 EP disclosed
EP-2342221-B1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS INC (US) 2018-11-07 EP disclosed
US-20180305400-A1 STABILIZED COMPOUNDS HAVING SECONDARY STRUCTURE MOTIFS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-10-25 US disclosed
US-9951099-B2 Stabilized compounds having secondary structure motifs PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-04-24 US disclosed
US-20170088581-A1 STABILIZED COMPOUNDS HAVING SECONDARY STRUCTURE MOTIFS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-03-30 US disclosed
US-9505801-B2 Stabilized compounds having secondary structure motifs PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-11-29 US disclosed
US-9394336-B2 Methods for preparing purified polypeptide compositions AILERON THERAPEUTICS, INC. (US) 2016-07-19 US disclosed
US-20160115204-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS, INC. 2016-04-28 US disclosed
US-20130211046-A1 Stabilized Compounds Having Secondary Structure Motifs PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-08-15 US disclosed
US-8324428-B2 Stabilized compounds having secondary structure motifs PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-12-04 US disclosed
US-20120264674-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS, INC. (US) 2012-10-18 US disclosed
EP-2342221-A2 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS Aileron Therapeutics, Inc. (US) 2011-07-13 EP disclosed
US-20110028753-A1 Stabilized Compounds Having Secondary Structure Motifs PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-02-03 US disclosed
US-7786072-B2 synthesizing a peptide from a selected number of natural or non-natural amino acids; stabilized p53 donor helical peptides PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-08-31 US disclosed
US-20100210515-A1 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTICS, INC. (US) 2010-08-19 US disclosed
WO-2010034032-A2 METHODS FOR PREPARING PURIFIED POLYPEPTIDE COMPOSITIONS AILERON THERAPEUTIC, INC. (US) 2010-03-25 WO disclosed
US-7192713-B1 synthesizing a peptide from a selected number of natural or non-natural amino acids; stabilized p53 donor helical peptides PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2007-03-20 US disclosed
US-20060008848-A1 synthesizing a peptide from a selected number of natural or non-natural amino acids; stabilized p53 donor helical peptides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2006-01-12 US disclosed